Results of comparing visits within allergy groups using linear mixed models and post hoc analysis. by Diana M. Hendrickx (1507435)

Results of comparing allergy groups within visits using linear mixed models and post hoc analysis. by Diana M. Hendrickx (1507435)

Development of immune factors over visits in the AAF-syn treatment group as (A) scores and (B) loadings when using the AAF treatment group as a reference. by Diana M. Hendrickx (1507435)

Results of comparing treatment groups within visits using linear mixed models and post hoc analysis. by Diana M. Hendrickx (1507435)

Proteins with at least one significant difference (adjusted p-value ≤ 0.05) between visits within allergy groups as determined by linear mixed models and post hoc analysis. by Diana M. Hendrickx (1507435)

Results of comparing visits within treatment groups using linear mixed models and post hoc analysis. by Diana M. Hendrickx (1507435)

Proteins with at least one significant difference (adjusted p-value ≤ 0.05) between visits within treatment groups as determined by linear mixed models and post hoc analysis. by Diana M. Hendrickx (1507435)

KEGG pathways (with at least 4 measured proteins) that have at least one significant difference (adjusted p-value (q-value) ≤ 0.05) between treatment groups within visits as determ... by Diana M. Hendrickx (1507435)

Results of comparing treatment groups within visits using KEGG pathway enrichment in ConsensusPathDB. by Diana M. Hendrickx (1507435)

Results of comparing allergy groups within visits using KEGG pathway enrichment in ConsensusPathDB. by Diana M. Hendrickx (1507435)

KEGG pathways (with at least 4 measured proteins) that have at least one significant difference (adjusted p-value (q-value) ≤ 0.05) between visits within treatment groups as determ... by Diana M. Hendrickx (1507435)

Results of comparing visits within treatment groups using KEGG pathway enrichment in ConsensusPathDB. by Diana M. Hendrickx (1507435)

KEGG pathways (with at least 4 measured proteins) that have at least one significant difference (adjusted p-value (q-value) ≤ 0.05) between visits within allergy groups as determin... by Diana M. Hendrickx (1507435)

Results of comparing visits within allergy groups using KEGG pathway enrichment in ConsensusPathDB. by Diana M. Hendrickx (1507435)

Potential mechanisms for persistent CMA (left) and resolution of CMA (right) revealed by our study. by Diana M. Hendrickx (1507435)

Aerosol Capture for Coupling to Microfluidics: A Miniaturized Low-Cost Device for Size-Resolved Particle Collection by Yao Xiao (227567)

Recording Harms in Behavioural change Intervention Trials (RHABIT) Project Protocol by Diana Papaioannou (2758093)

“…It consists of 4 work packages (WP): WP1 Scoping review of literature to identify definitions, typologies, instruments, and suggested principles for recording harms in behavioural change intervention (BCI) trials; WP2 Qualitative interviews with clinical trials unit (CTU) and NIHR investigators involved in designing and delivering BCI trials; WP3 Workshop(s) to review guidance for recording harms in BCI trials; and WP4 Suggested principles and considerations for harms recording in BCI trials.…”

Paper-Like Visual Indicator Films for Harmful Hydrophilic Liquids and Vapors by Shuangxi Tang (8854715)

“…Herein, we develop an indicator film that can easily respond to harmful hydrophilic liquids and gases and allow for the visual recognition of a transparency transformation involving hydrated poly­(<i>N</i>-isopropylacrylamide). …”

Paper-Like Visual Indicator Films for Harmful Hydrophilic Liquids and Vapors by Shuangxi Tang (8854715)

“…Herein, we develop an indicator film that can easily respond to harmful hydrophilic liquids and gases and allow for the visual recognition of a transparency transformation involving hydrated poly­(<i>N</i>-isopropylacrylamide). …”

Paper-Like Visual Indicator Films for Harmful Hydrophilic Liquids and Vapors by Shuangxi Tang (8854715)

“…Herein, we develop an indicator film that can easily respond to harmful hydrophilic liquids and gases and allow for the visual recognition of a transparency transformation involving hydrated poly­(<i>N</i>-isopropylacrylamide). …”